Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

Data as of Oct 21
 -1.44 / -1.01%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Salix Pharmaceuticals Ltd. is a specialty pharmaceutical company, which acquires, develops and commercializes prescription drugs and medical devices used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. It offers products such as Anusol, Proctocort, Apriso, Azasan, Colazal, Deflux, Diuril, Metozolv ODT, MoviPrep, OsmoPrep, Pepcid, Relistor, Visicol, Xifaxan 550 mg and Xifaxan 200 mg. The company was founded by Randy W. Hamilton and Lorin K. Johnson was founded in December 1993 and is headquartered in Raleigh, NC.

Contact Information

Salix Pharmaceuticals Ltd.
8510 Colonnade Center Drive
Raleigh North Carolina 27615
P:(919) 862-1000
Investor Relations:



Mutual fund holders60.25%
Other institutional48.88%
Individual stakeholders12.65%

Top Executives

Carolyn J. LoganPresident, Chief Executive Officer & Director
Adam C. DerbyshireCFO, Executive VP-Finance & Administration
William P. ForbesChief Development Officer, EVP-Medical & Research
Richard D. ScruggsExecutive Vice President-Business Development
Timothy J. CreechSenior VP-Finance & Administrative Services

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.